This idea is supported by other neurodegenerative diseases experiencing severe localized copper deficiency, such as the motor neurons of ALS patients (Hilton et al., 2024), PD patients with up to 50% reduction of copper seen in the substantia nigra (Bisaglia and Bubacco, 2020), brain copper reductions in prion diseases (Sorenson, 2001), and notably Menkes disease which is characterized by an X-linked defect in copper transporting ATP7-A gene that leads to severe systemic copper deficiency and progressive neurodegeneration (Tmer and Mller, 2010)
Front Oncol 13:1257767 Avancini A, Borsati A, Toniolo L, Ciurnelli C, Belluomini L, Budolfsen T et al (2025) Physical activity guidelines in oncology: a systematic review of the current recommendations
Whether youre new to peptide therapy or optimizing your current protocol, understanding evidence-based dosing is critical for achieving your metabolic health goals safely and effectively
Plasma carnitine in pregnancy